It has also been demonstrated that IGF2BP3 is required to maintain the survival of AML cells in an m6A-dependent manner and that IGF2BP3 functions to promote AML progression by interacting with RCC2 mRNA and stabilizing the expression of m6A-modified RNA (133). The gene discussed is RCC2; the disease is acute myeloid leukemia.